Savvy Trades and Investments

[dickmilde]

‘Bubble Boy’ MBIO Biotech Soars 250 Percent After Cure Announcement

(Bloomberg) -- Shares of the tiny biotechnology company Mustang Bio Inc. more than tripled Thursday, following a scientific breakthrough that cured eight infants suffering from the devastating “Bubble Boy” immune system disorder.

"Mustang Bio is focused mainly on developing novel immunotherapies for cancer and is still working to bring its first product to market. It plans to file for U.S. Food and Drug Administration approval for the gene therapy based mainly on the data in the publication, after it confirms the benefits in a handful of additional children treated with the therapy crafted in its Worcester, Massachusetts, manufacturing facility. The filing could occur by the end of 2021, said Chief Executive Officer Manny Litchman."

https://finance.yahoo.com/news/mustang-bio-soars-485-novel-231626171.html